“The flu is a formidable foe,” said Sen. Ed Markey, D-Mass. “This year, all signs are pointing to the most severe flu season since the 2009 pandemic.”
The growing number of pediatric flu deaths across the country and preliminary vaccine findings for this year, which reported the current vaccine is only 36 percent effective, sparked the proposal.
Mr. Markey and the bill’s cosponsors aim to give $200 million per year to the National Institutes of Health to develop a vaccine that protects against all flu strains.
“It’s just something that we don’t accept in a country that has had so many medical developments,” said Sen. Amy Klobuchar, D-Minn.
Mr. Markey said a front-end investment in this treatment is worthwhile to cut U.S. spending on the flu, which costs about $10.4 billion in direct medical costs on average each year and $87 billion to the overall economy.
More articles on healthcare quality:
Hospitals may fail to diagnose flu in older patients: 5 findings
Certain ischemic stroke patients may benefit significantly from thrombectomy procedures
Standardized handover between OR & ICU reduces errors, increases provider satisfaction
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.